SANOFI-AVENTIS (EPA:SAN) | Finanzwire

Basculer en Français

9821	Companies
197095	Keywords
128171	Articles
104822	Press releases

Home
Companies
SANOFI-AVENTIS

PRESS RELEASE

published on 12/24/2025 at 07:00, 1 month 14 days ago

Press Release: Sanofi provides update on tolebrutinib regulatory submission in non-relapsing secondary progressive multiple sclerosis
Sanofi provides update on tolebrutinib regulatory submission for non-relapsing secondary progressive multiple sclerosis, with FDA issuing a complete response letter and further guidance expected in Q1 2026

FDA Multiple Sclerosis Sanofi Tolebrutinib Regulatory Submission
BRIEF

published on 12/23/2025 at 15:11, 1 month 15 days ago

Sanofi's Wayrilz receives EU approval for the treatment of IPT

EU Sanofi TPI Wayrilz BTK
BRIEF

published on 12/23/2025 at 15:11, 1 month 15 days ago

Sanofi's Wayrilz Gets EU Approval for Treating Immune Thrombocytopenia

Sanofi EU Approval BTK Inhibitor Wayrilz Immune Thrombocytopenia
PRESS RELEASE

published on 12/23/2025 at 15:06, 1 month 15 days ago

Press Release: Sanofi’s Wayrilz approved in the EU as the first BTK inhibitor to treat immune thrombocytopenia
Sanofi's Wayrilz, a novel BTK inhibitor, approved in the EU for treating immune thrombocytopenia. Offers multi-immune modulation for ITP management

Sanofi BTK Inhibitor Wayrilz Immune Thrombocytopenia Multi-immune Modulation
BRIEF

published on 12/23/2025 at 07:05, 1 month 15 days ago

Sanofi and Regeneron's Dupixent approved in Japan for children with asthma

Japan Sanofi Dupixent Regeneron Childhood Asthma
BRIEF

published on 12/23/2025 at 07:05, 1 month 15 days ago

Sanofi and Regeneron's Dupixent Gains Approval in Japan for Young Asthma Patients

Sanofi Dupixent Japan Approval Regeneron Asthma
PRESS RELEASE

published on 12/23/2025 at 07:00, 1 month 15 days ago

Press Release: Sanofi and Regeneron’s Dupixent approved in Japan for children aged 6 to 11 years with bronchial asthma
Sanofi and Regeneron's Dupixent approved in Japan for children aged 6 to 11 years with bronchial asthma, showing significant reduction in exacerbations and improved lung function in phase 3 studies

Sanofi Phase 3 Study Dupixent Regeneron Bronchial Asthma
BRIEF

published on 12/22/2025 at 18:40, 1 month 16 days ago

Sanofi Provides Update on Voting Rights and Shares for November 2025

Voting Rights Treasury Shares Issued Shares Sanofi November 2025
PRESS RELEASE

published on 12/22/2025 at 18:35, 1 month 16 days ago

Sanofi: Information concerning the total number of voting rights and shares - November 2025
Sanofi discloses total voting rights and shares under French regulations. Details available on website. Contact Investor Relations Department for more information

Voting Rights Shares French Regulations Investor Relations Sanofi
BRIEF

published on 12/19/2025 at 20:26, 1 month 19 days ago

Sanofi Agreement with US Government to Lower Medicine Costs

Innovation Healthcare Savings US Government Sanofi Agreement Medicine Costs

Accesswire

Published on 02/07/2026 at 01:00, 1 day 2 hours ago

Green Bridge Metals Can Help Secure U.S. Production of Critical Mineral Titanium
Published on 02/06/2026 at 23:10, 1 day 4 hours ago

Topline Capital Management, LLC Announces Disposition of Shares of NamSys Inc.
Published on 02/06/2026 at 22:01, 1 day 5 hours ago

Totec Resources Announces Listing of Shares on the Frankfurt Stock Exchange and Adoption of Omnibus Incentive Plan
Published on 02/06/2026 at 15:30, 1 day 12 hours ago

Vulcan Minerals Inc. - Drilling Program Update for the Carbonear Zinc-Lead SEDEX project in Newfoundland
Published on 02/06/2026 at 13:30, 1 day 14 hours ago

Redwood AI Corp. (formerly Marshall Technologies Corp.) Announces Closing of IPO and Listing of Shares on the Canadian Securities Exchange

View all ACCESSWIRE

EQS Group

Published on 02/07/2026 at 21:00, 6 hours 43 minutes ago

Alibaba Group Debuts 'Wonder on Ice,' an Immersive AI Experience at Milan’s Sforza Castle for Milano Cortina 2026
Published on 02/07/2026 at 16:35, 11 hours 8 minutes ago

The Ministry of Finance and the International Monetary Fund to launch tomorrow the second edition of the AlUla Conference for Emerging Market Economies
Published on 02/07/2026 at 16:20, 11 hours 23 minutes ago

NOTICE OF SETTLEMENT APPROVAL HEARING - SHORT FORM - WAYLAND GROUP CORP., SCOTT LANGILLE, GERHARD MÜLLER, PAUL PATHAK, ERIC SILVER, MICHAEL STEIN, JOHN DOES 1-3, CANACCORD GENUITY CORP., AND RF SECURITIES CLEARING LP (FORMERLY KNOWN AS GMP SECU
Published on 02/06/2026 at 19:25, 1 day 8 hours ago

Funding Circle Holdings plc: POS-Transaction in Own Shares
Published on 02/06/2026 at 17:52, 1 day 9 hours ago

EQS-Adhoc: Avemio AG: Preparation of the filing for insolvency proceedings by Teltec AG, a subsidiary of Avemio AG, and potential effects on the going-concern assessment of Avemio AG

Les Echos

Published on 02/06/2026 at 18:22, 1 day 9 hours ago

Disclosure of Share Capital and Voting Rights as of January 31, 2026
Published on 02/06/2026 at 16:01, 1 day 11 hours ago

Notice of exercise of early redemption option of the subordinated note ISIN : FR0010093328
Published on 02/05/2026 at 19:24, 2 days 8 hours ago

Minutes of the Combined General Meeting
Published on 02/05/2026 at 18:24, 2 days 9 hours ago

LNA SANTE : 2025 annual sales
Published on 02/05/2026 at 18:06, 2 days 9 hours ago

Aéroports de Paris SA - Shares and voting rights as of 31 January 2026

View all LES ECHOS COMFI WIRE